BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 27338641)

  • 21. Regulatory role of lymphoid chemokine CCL19 and CCL21 in the control of allergic rhinitis.
    Takamura K; Fukuyama S; Nagatake T; Kim DY; Kawamura A; Kawauchi H; Kiyono H
    J Immunol; 2007 Nov; 179(9):5897-906. PubMed ID: 17947663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of CCL19 by DC-Lamp+ mature dendritic cells in human lymph node versus chronically inflamed skin.
    Katou F; Ohtani H; Nakayama T; Nagura H; Yoshie O; Motegi K
    J Pathol; 2003 Jan; 199(1):98-106. PubMed ID: 12474232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ACKR4 on Stromal Cells Scavenges CCL19 To Enable CCR7-Dependent Trafficking of APCs from Inflamed Skin to Lymph Nodes.
    Bryce SA; Wilson RA; Tiplady EM; Asquith DL; Bromley SK; Luster AD; Graham GJ; Nibbs RJ
    J Immunol; 2016 Apr; 196(8):3341-53. PubMed ID: 26976955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased levels of CCR7 ligands in carotid atherosclerosis: different effects in macrophages and smooth muscle cells.
    Halvorsen B; Dahl TB; Smedbakken LM; Singh A; Michelsen AE; Skjelland M; Krohg-Sørensen K; Russell D; Höpken UE; Lipp M; Damås JK; Holm S; Yndestad A; Biessen EA; Aukrust P
    Cardiovasc Res; 2014 Apr; 102(1):148-56. PubMed ID: 24518141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combinatorial guidance by CCR7 ligands for T lymphocytes migration in co-existing chemokine fields.
    Nandagopal S; Wu D; Lin F
    PLoS One; 2011 Mar; 6(3):e18183. PubMed ID: 21464944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated concentrations of CCR7 ligands in patients with eosinophilic pneumonia.
    Nureki S; Miyazaki E; Ishi T; Ito T; Takenaka R; Ando M; Kumamoto T
    Allergy; 2013 Nov; 68(11):1387-95. PubMed ID: 24111618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Baicalin attenuates inflammation in mice with OVA-induced asthma by inhibiting NF-κB and suppressing CCR7/CCL19/CCL21.
    Liu J; Wei Y; Luo Q; Xu F; Zhao Z; Zhang H; Lu L; Sun J; Liu F; Du X; Li M; Wei K; Dong J
    Int J Mol Med; 2016 Nov; 38(5):1541-1548. PubMed ID: 27666000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of homeostatic chemokines CCL19 and CCL21 and their receptor CCR7 to coronary artery disease.
    Cai W; Tao J; Zhang X; Tian X; Liu T; Feng X; Bai J; Yan C; Han Y
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1933-41. PubMed ID: 24990231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CCL21 is sufficient to mediate DC migration, maturation and function in the absence of CCL19.
    Britschgi MR; Favre S; Luther SA
    Eur J Immunol; 2010 May; 40(5):1266-71. PubMed ID: 20201039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The N-terminal domain of CCL21 reconstitutes high affinity binding, G protein activation, and chemotactic activity, to the C-terminal domain of CCL19.
    Ott TR; Lio FM; Olshefski D; Liu XJ; Ling N; Struthers RS
    Biochem Biophys Res Commun; 2006 Sep; 348(3):1089-93. PubMed ID: 16904643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural Features of an Extended C-Terminal Tail Modulate the Function of the Chemokine CCL21.
    Moussouras NA; Hjortø GM; Peterson FC; Szpakowska M; Chevigné A; Rosenkilde MM; Volkman BF; Dwinell MB
    Biochemistry; 2020 Apr; 59(13):1338-1350. PubMed ID: 32182428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CCL19/CCL21-Dependent Chemotaxis of Dendritic Cells in Healthy Individuals and Patients with Brain Tumors.
    Tyrinova TV; Leplina OY; Tikhonova MA; Mishinov SV; Stupak VV; Ostanin AA; Chernykh ER
    Bull Exp Biol Med; 2015 Apr; 158(6):785-8. PubMed ID: 25894778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ectopic lymphoid tissue alters the chemokine gradient, increases lymphocyte retention and exacerbates murine ileitis.
    McNamee EN; Masterson JC; Jedlicka P; Collins CB; Williams IR; Rivera-Nieves J
    Gut; 2013 Jan; 62(1):53-62. PubMed ID: 22267601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solution Structure of CCL19 and Identification of Overlapping CCR7 and PSGL-1 Binding Sites.
    Veldkamp CT; Kiermaier E; Gabel-Eissens SJ; Gillitzer ML; Lippner DR; DiSilvio FA; Mueller CJ; Wantuch PL; Chaffee GR; Famiglietti MW; Zgoba DM; Bailey AA; Bah Y; Engebretson SJ; Graupner DR; Lackner ER; LaRosa VD; Medeiros T; Olson ML; Phillips AJ; Pyles H; Richard AM; Schoeller SJ; Touzeau B; Williams LG; Sixt M; Peterson FC
    Biochemistry; 2015 Jul; 54(27):4163-6. PubMed ID: 26115234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central Nervous System and Peripheral Expression of CCL19, CCL21 and Their Receptor CCR7 in Experimental Model of Multiple Sclerosis.
    Bielecki B; Jatczak-Pawlik I; Wolinski P; Bednarek A; Glabinski A
    Arch Immunol Ther Exp (Warsz); 2015 Oct; 63(5):367-76. PubMed ID: 25957582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polysialylated neuropilin-2 enhances human dendritic cell migration through the basic C-terminal region of CCL21.
    Rey-Gallardo A; Escribano C; Delgado-Martín C; Rodriguez-Fernández JL; Gerardy-Schahn R; Rutishauser U; Corbi AL; Vega MA
    Glycobiology; 2010 Sep; 20(9):1139-46. PubMed ID: 20488940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autocrine CCL19 blocks dendritic cell migration toward weak gradients of CCL21.
    Hansen M; Met Ö; Larsen NB; Rosenkilde MM; Andersen MH; Svane IM; Hjortø GM
    Cytotherapy; 2016 Sep; 18(9):1187-96. PubMed ID: 27424146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis.
    Alt C; Laschinger M; Engelhardt B
    Eur J Immunol; 2002 Aug; 32(8):2133-44. PubMed ID: 12209625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of CCR7 and its ligands CCL19/CCL21 in muscles of polymyositis.
    Tateyama M; Fujihara K; Misu T; Feng J; Onodera Y; Itoyama Y
    J Neurol Sci; 2006 Nov; 249(2):158-65. PubMed ID: 16887149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Novel Computational Model Predicts Key Regulators of Chemokine Gradient Formation in Lymph Nodes and Site-Specific Roles for CCL19 and ACKR4.
    Jafarnejad M; Zawieja DC; Brook BS; Nibbs RJB; Moore JE
    J Immunol; 2017 Oct; 199(7):2291-2304. PubMed ID: 28807994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.